Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Immunome Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +46 vs. Q4 2023
- Shares held
- 36.6M
- +15.1M (+70.4%) vs. Q4 2023
- Total value
- $903.6M
- +$673.7M (+293.0%) vs. Q4 2023
- New holders
- 57
- 29 more added
- Sold out
- 11
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $2.50B |
| Q1 2026 | 202 | $2.54B |
| Q4 2025 | 183 | $2.54B |
| Q3 2025 | 153 | $1.07B |
| Q2 2025 | 142 | $738.7M |
| Q1 2025 | 143 | $518.4M |
| Q4 2024 | 121 | $566.3M |
| Q3 2024 | 115 | $754.7M |
| Q2 2024 | 114 | $578.4M |
| Q1 2024 | 103 | $903.6M |
| Q4 2023 | 57 | $229.9M |
| Q3 2023 | 35 | $19.7M |
| Q2 2023 | 35 | $15.4M |
| Q1 2023 | 30 | $9.34M |
| Q4 2022 | 28 | $4.85M |
| Q3 2022 | 24 | $10.7M |
| Q2 2022 | 26 | $7.78M |
| Q1 2022 | 29 | $15.4M |
| Q4 2021 | 30 | $36.4M |
| Q3 2021 | 35 | $58.3M |
| Q2 2021 | 29 | $41.1M |
| Q1 2021 | 31 | $64.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 3,879,415 | $95.7M | 2.43% | 00.0% | Unchanged |
| FMR LLC | 4,534,643 | $111.9M | 0.01% | +628,500+16.1% | Added |
| Redmile Group, LLC | 4,889,554 | $120.7M | 4.43% | +1,010,139+26.0% | Added |
| Prentice Capital Management, LP | 0 | $0 | 0.00% | −112,131−100.0% | Sold out |
| Mayo Clinic | 0 | $0 | 0.00% | −108,480−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −27,149−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −16,818−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −16,100−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −15,844−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,054−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,630−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −225−100.0% | Sold out |